Antirheumatic in SARS-CoV-2: benefit or risk?

Submitted: 15 April 2020
Accepted: 28 April 2020
Published: 29 April 2020
Abstract Views: 1720
PDF: 467
HTML: 6
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Not available

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Ferrara, F. (2020). Antirheumatic in SARS-CoV-2: benefit or risk?. Italian Journal of Medicine, 14(2), 114–115. https://doi.org/10.4081/itjm.2020.1290

List of Cited By :

Crossref logo